Member access

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

NOVO NORDISK A/S (NOVO.B)

188
Delayed Quote. Delayed BATS Europe - 12/18 03:18:49 am
264.75 DKK   +1.87%
3d ago Novo Nordisk A/S - Share repurchase programme
3d ago SILENCE THERAPE : Appoints Karlsson Head Of Research & Development
6d ago NOVO NORDISK A/ : Brings One-Stop Diabetes Care to African Cities
SummaryChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on NOVO NORDISK A/S
1d ago NOVO NORDISK A/S : Recent Findings in Gestational Diabetes Described by Research..
1d ago NOVO NORDISK A/S : Launches Community Health Collaborative™ Aimed At Impro..
1d ago NOVO NORDISK A/S : and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship..
1d ago NOVO NORDISK A/S : Enters Into Agreement with Chip Ganassi Racing
3d ago Novo Nordisk A/S - Share repurchase programme
3d ago SILENCE THERAPEUTICS : Appoints Karlsson Head Of Research & Development
6d ago NOVO NORDISK A/S : Brings One-Stop Diabetes Care to African Cities
7d ago NOVO NORDISK A/S : Places R&D Under the Microscope
7d ago NOVO NORDISK A/S : Group Launches Diabetes Centres in Edo
12/10 HYBIO PHARMACEUTICAL : Patent Application Titled "Method for Solid Phase Synthes..
12/10 NOVO NORDISK A/S : Findings in Bovine Serum Albumin Reported from Novo Nordisk (..
12/10 NOVO NORDISK A/S : Effia Nkwanta records 250 plus diabetes annually
12/09 NOVO NORDISK A/S : reports positive results from phase III trial of NovoEight in..
12/09 NOVO NORDISK A/S : -Share repurchase programme
12/09 NOVO NORDISK A/S : Strativity Presents New Customer Experience Learning Program:..
12/08 PER AARSLEFF A/S : Aarsleff to build shell structure for Novo Nordisk A/S
12/08 Novo Nordisk A/S - Share repurchase programme
12/06 SANOFI : Drugmaker Sanofi fired her for whistleblowing over alleged kickbacks to..
12/06 NOVO NORDISK A/S : Developers marketing Plainsboro office site
12/05 SANOFI : fired her for whistleblowing (Paralegal)
12/05 NOVO NORDISK A/S : DHF receives $200,000 grant from Novo Nordisk
12/03 NOVO NORDISK A/S : Researchers from Novo Nordisk Report Recent Findings in Diabe..
12/03 NOVO NORDISK A/S : to Present Hemophilia Portfolio and Pipeline Data at 56th Ame..
12/02 NOVO NORDISK A/S : Share repurchase programme
12/01 NOVO NORDISK A/S : Share repurchase programme
12/01 NOVO NORDISK A/S : Novo Nordisk A/S - Share repurchase programme
11/26 NOVO NORDISK A/S : Findings from Novo Nordisk Reveals New Findings on Hematology..
11/26 NOVO NORDISK A/S : Case Study Shows Path to Lowering Costs and Improving Diabete..
11/26 NOVO NORDISK A/S : Study Results from Novo Nordisk Provide New Insights into Dia..
11/26 NOVO NORDISK A/S : Details Findings in Proinsulin (Changes in Glucose and Fat Me..
11/25 ELI LILLY : Gets European Approval to Sell Trulicity, a Type 2 Diabetes Drug
11/25 NOVO NORDISK A/S : Changes in Novo Nordisk's Executive Management
11/24 NOVO NORDISK A/S : Changes in Novo Nordisk's Executive Management
11/24 NOVO NORDISK A/S : Changes in Novo Nordisk's Executive Management
11/24 NOVO NORDISK A/S : Grant Enables Trenton Health Team to Engage Faith-Based Organ..
11/24 NOVO NORDISK A/S : Victoza gets CHMP positive opinion to treat adults with type ..
11/24 NOVO NORDISK A/S : Share repurchase programme
11/24 Novo Nordisk A/S - Share repurchase programme
11/21 NOVO NORDISK A/S : Victoza® receives positive CHMP opinion for use in adults wit..
11/19 NOVO NORDISK A/S : Patent Issued for Single-Chain Insulin
11/19 NOVO NORDISK A/S : Patent Issued for Human Insulin Containing Additional Disulfi..
11/17 NOVO NORDISK A/S : -Tianjin and Shanghai join Cities Changing Diabetes on World ..
11/17 Novo Nordisk A/S - Share repurchase programme
11/17 NOVO NORDISK A/S : second best in the world at providing access to medicine
11/12 NOVO NORDISK A/S : Researchers from Novo Nordisk Provide Details of New Studies ..
11/12 NOVO NORDISK A/S : Research Conducted at Novo Nordisk Has Updated Our Knowledge ..
11/12 NOVO NORDISK A/S : City of Houston and Novo Nordisk Partner to Lead Fight Agains..
11/12 NOVO NORDISK A/S : High number of diabetics causes alarm
11/11 NOVO NORDISK A/S : Share repurchase programme
11/10 NOVO NORDISK A/S : Novo Nordisk A/S - Share repurchase programme
11/06 Novo Nordisk A/S - Trading in Novo Nordisk shares by board members, executive..
11/05 Analysis - Drugmakers look to push the boundaries of old age
11/05 NOVO NORDISK A/S : now hiring for new manufacturing facility in New Hampshire
11/05 NOVO NORDISK A/S : Announces U.S. Launch of NovoFine® Plus, a New Pen Needle for..
11/04 NOVO NORDISK A/S : Media Release - Top 100 Employer
11/04 NOVO NORDISK A/S : City of Houston and Novo Nordisk Partner to Lead Fight Agains..
11/04 NOVO NORDISK A/S : New phase 3a data demonstrate that 9 out of 10 adults with ob..
11/03 NOVO NORDISK A/S : invests $126m on new diabetes labs at MÃ¥løv R&D campus
11/03 NOVO NORDISK A/S : invests DKK 750 million in new laboratories for diabetes rese..
11/03 NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
11/03 NOVO NORDISK A/S : invests DKK 750 million in new laboratories for diabetes rese..
11/03 NOVO NORDISK A/S : and Roche Diabetes Care launch new treatment option to simpli..
11/03 NOVO NORDISK A/S : City of Houston and partner to lead fight against urban diabe..
10/31 NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
10/31 Novo Nordisk A/S - Trading in Novo Nordisk shares by board members, executive..
10/31DJNOVO NORDISK A/S : Spends DKK750 Million on New Diabetes Resarch Lab
10/31 NOVO NORDISK A/S : invests DKK 750 million in new laboratories for diabetes rese..
10/30DJEUROPE MARKETS : European Stocks Climb For Third Straight Day
10/30DJEUROPE MARKETS : European Stocks Fall For First Time In Three Days
10/30 NOVO NORDISK A/S : now hiring for new manufacturing facility in New Hampshire
10/30DJEUROPE MARKETS : European Stocks Falls For First Time In Three Days
10/30 Novo Nordisk increased operating profit in local currencies by 11% in the fir..
10/29 NOVO NORDISK A/S : Patent Issued for Pharmaceutical Solution of Non Covalently B..
10/29 NOVO NORDISK A/S : Investigators from Novo Nordisk Zero in on Diabetes (Clinical..
10/29 NOVO NORDISK A/S : Diabetes Education Program Receives NCQA Disease Management C..
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF